Organisation paid for research Program year 2025 Source: CMS Open Payments

Uso Texas Oncology

Neither a doctor nor a teaching hospital

Research payments

$897,760

14 payments

Through program year 2025, Uso Texas Oncology is reported as receiving $897,760 in research payments, across 14 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$469,600	8
2024	Research	$371,760	5
2021	Research	$56,400	1

Breakdown

Who paid Research payments · program years 2021–2025

BeiGene, Ltd. $530,960 8 payments
BeOne Medicines Ltd. $366,800 6 payments

Studies the money was for Research payments · program years 2021–2025

An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Patients With B-cell Malignancies $841,360 13 payments
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib $56,400 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.